Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;31(4):472-9.
doi: 10.1007/s12288-014-0454-5. Epub 2014 Sep 3.

IgG Lambda Myeloma Presenting as Plasmacytic Ascites: Case Report and Review of Literature

Affiliations

IgG Lambda Myeloma Presenting as Plasmacytic Ascites: Case Report and Review of Literature

Subhashis Mitra et al. Indian J Hematol Blood Transfus. 2015 Dec.

Abstract

Multiple myeloma is a neoplastic disease of plasma cells accounting for 13 % of haematological malignancies and 2 % of all malignancies worldwide. Ascites may develop very rarely during the course of disease in multiple myeloma. We report the case of a 78 years old male with IgG lambda multiple myeloma who initially presented with plasmacytic ascites. An exhaustive review of world literature reveals 65 cases of ascites to have been reported in myeloma over a span of 62 years (1952 till date), usually developing in the course of treatment. This is the 7th case of plasmacytic ascites to have been diagnosed at initial presentation. We review the clinical features, diagnosis, prognostic significance and treatment of such cases.

Keywords: Ascites; IgG lambda; Multiple myeloma; Plasmacytic ascites.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
a CT (Computed tomography) scans of abdomen showing mesenteric thickening and peritoneal nodules b Bone marrow aspirate smears with increased plasma cells, and bi nucleate forms (modified Wright-Giemsa stain, ×400) c Numerous plasma cells in cell block preparation (modified Wright-Giemsa stain, ×400) d CD 138 positivity in plasma cells, cell block preparation (Immunoperoxidase, ×400)

Similar articles

Cited by

References

    1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics 2008. CA Cancer J Clin. 2008;58:71–96. doi: 10.3322/CA.2007.0010. - DOI - PubMed
    1. Bergasel DE, Bergasel PL. Epidemiology and etiology of plasma cell neoplasms. In: Gahrton G, Durie BGM, Samson DM, editors. Multiple myeloma and related disorders. London: Arnold; 2001. pp. 15–26.
    1. Becker N. Epidemiology of multiple myeloma. Recent Results Cancer Res. 2011;183:25–35. doi: 10.1007/978-3-540-85772-3_2. - DOI - PubMed
    1. Gupta M, Pal RAGK, Tikoo D. Multiple myeloma: the disease and its treatment. Int J Basic Clin Pharmacol. 2013;2(2):103–121. doi: 10.5455/2319-2003.ijbcp20130302. - DOI
    1. Kumar L, Vikram P, Kochupillai V. Recent advances in the management of multiple myeloma. Natl Med J India. 2006;19:80–89. - PubMed

LinkOut - more resources